A. Serraf et al., PULMONARY-HYPERTENSION IN INFANTS WITH CONGENITAL HEART-DEFECTS - ARELEUKOTRIENES INVOLVED, Mediators of inflammation, 6(5-6), 1997, pp. 323-326
The circulating levels of leukotriene E-4 in infants with congenital h
eart defects, increased pulmonary blood flow and pulmonary arterial hy
pertension, were determined and compared with infants with decreased p
ulmonary blood flow (Tetralogy of Fallot). There was no correlation (r
= 0.38) between the pulmonary arterial pressure (56 +/- 4 mmHg) and t
he leukotriene E-4 levels (1.37 +/- 0.67 ng/ml blood) measured in peri
pheral blood samples from the hypertensive group prior to surgery. The
re was considerable variation in the detectable leukotriene E-4 levels
in blood samples from different patients, The levels detected in the
blood samples between the two groups of patients was similar, These da
ta suggest that neither the surgical repair during cardiopulmonary byp
ass nor the pulmonary hypertension appeared to modify the leukotriene
E-4 blood levels in the small number of patients studied.